Schizophrenia treatment study challenges common practice of combining antipsychotics

A major U.S. study of nearly 62,000 schizophrenia patients found that doctors frequently prescribe multiple antipsychotic drugs together, despite limited evidence this approach is safer or more effective than single-drug treatment. The findings could reshape clinical guidelines and reduce costs for insurers and healthcare systems managing one of psychiatry's most expensive chronic conditions.

Originaltitel: Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia